Eaton Vance Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $179M | Sell |
|
|||||
|
2022
Q2 | $228M | Buy |
|
|||||
|
2022
Q1 | $271M | Buy |
|
|||||
|
2021
Q4 | $275M | Buy |
|
|||||
|
2021
Q3 | $274M | Buy |
|
|||||
|
2021
Q2 | $201M | Buy |
|
|||||
|
2021
Q1 | $189M | Buy |
|
|||||
|
2020
Q4 | $161M | Buy |
|
|||||
|
2020
Q3 | $80M | Buy |
|
|||||
|
2020
Q2 | $77.1M | Buy |
|
|||||
|
2020
Q1 | $46.4M | Buy |
|
|||||
|
2019
Q4 | $26.7M | Buy |
|
|||||
|
2019
Q3 | $12.3M | Buy |
|
|||||
|
2019
Q2 | $6.75M | Buy |
|
|||||
|
2019
Q1 | $6.03M | Sell |
|
|||||
|
2018
Q4 | $4.91M | Sell |
|
|||||
|
2018
Q3 | $7.27M | Sell |
|
|||||
|
2018
Q2 | $7.21M | Sell |
|
|||||
|
2018
Q1 | $15M | Buy |
|
|||||
|
2017
Q4 | $6.32M | Sell |
|
|||||
|
2017
Q3 | $10.8M | Sell |
|
|||||
|
2017
Q2 | $11.8M | Sell |
|
|||||
|
2017
Q1 | $9.34M | Sell |
|
|||||
|
2016
Q4 | $10.4M | Sell |
|
|||||
|
2016
Q3 | $10.1M | Sell |
|
|||||
|
2016
Q2 | $18.1M | Sell |
|
|||||
|
2016
Q1 | $23.8M | Buy |
|
|||||
|
2015
Q4 | $18.8M | Sell |
|
|||||
|
2015
Q3 | $24.1M | Buy |
|
|||||
|
2015
Q2 | $11.9M | Sell |
|
|||||
|
2015
Q1 | $11.4M | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $2.94M | Buy |
|